Functional and molecular imaging of breast tumors;Funktionelle und molekulare Bildgebung bei Brusttumoren

Radiologe

Volumn 50, Issue 11, 2010, Pages 1030-1038

  Pinker, K ^a   Brader, P ^a   Karanikas, G ^b   El Rabadi, K ^a   Bogner, W ^b   Gruber, S ^b   Reisegger, M ^a   Trattnig, S ^b   Helbich, T H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIV KLIN FÜR RADIODIAGNOSTIK   (Austria)

Author keywords

Diffusion weighted imaging (DWI); Magnetic resonance spectroscopic imaging (MRSI); Molecular imaging; Optical imaging; Positron emission tomography magnetic resonance imaging (PET MRI)

Indexed keywords

CONTRAST MEDIUM;

ARTICLE; BREAST TUMOR; CANCER STAGING; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; FEMALE; GENETICS; HUMAN; INSTRUMENTATION; LYMPH NODE METASTASIS; METHODOLOGY; MOLECULAR DIAGNOSIS; PATHOLOGY; PERSONALIZED MEDICINE; PREDICTIVE VALUE; PROGNOSIS; TREATMENT OUTCOME;

BREAST NEOPLASMS; CONTRAST MEDIA; DIAGNOSTIC IMAGING; FEMALE; HUMANS; INDIVIDUALIZED MEDICINE; LYMPHATIC METASTASIS; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TREATMENT OUTCOME;

EID: 78649930467     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00117-010-2014-9     Document Type: Article

References (25)

1. Weissleder R, Mahmood U (2001) Molecular imaging. Radiology 219(2):316-333
2. Helbich TH, Becherer A, Trattnig S et al (1997) Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography. Radiology 202(2):421-429
3. Brem RF, Rapelyea JA, Zisman G et al (2005) Occult breast cancer: scintimammography with high-resolution breast-specific gamma camera in women at high risk for breast cancer. Radiology 237(1):274-280
4. Khalkhali I, Baum JK, Villanueva-Meyer J et al (2002) (99m) Tc sestamibi breast imaging for the examination of patients with dense and fatty breasts: multicenter study. Radiology 222(1):149-155
5. Berg WA, Weinberg IN, Narayanan D et al (2006) High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer. Breast J 12(4):309-323
6. Kenny L, Coombes RC, Vigushin DM et al (2007) Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography. Eur J Nucl Med Mol Imaging 34(9):1339-1347
7. Rajendran JG, Mankoff DA, O'Sullivan F et al (2004) Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Clin Cancer Res 10(7):2245-2252
8. Kuhl CK, Jost P, Morakkabati N et al (2006) Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience. Radiology 239(3):666-676
9. Bartella L, Smith CS, Dershaw DD, Liberman L (2007) Imaging breast cancer. Radiol Clin North Am 45(1):45-67
10. Jagannathan NR, Kumar M, Seenu V et al (2001) Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 84(8):1016-1022
11. Bogner W, Gruber S, Pinker K et al (2009) Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis? Radiology 253:341-351
12. Bogner W P K, Gruber S, Grabner G et al (2008) High-field diffusion-weighted imaging for improved differentiation of benign and malignant breast lesions. RSNA 2008. Chicago, USA
13. Yankeelov TE, Lepage M, Chakravarthy A et al (2007) Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging 25(1):1-13
14. Woodhams R, Matsunaga K, Iwabuchi K et al (2005) Diffusion-weighted imaging of malignant breast tumors - the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr 29(5):644-649
15. Bogner W P K, Gruber S, Grabner G et al (2009) Diffusion-weighted MRI for differentiation of breast lesions at 3.0 tesla: how does selection of diffusion schemes affect diagnosis? Radiology, in press
16. Pichler BJ, Judenhofer MS, Catana C et al (2006) Performance test of an LSO-APD detector in a 7-T MRI scanner for simultaneous PET/MRI. J Nucl Med 47(4):639-647
17. Wehrl HF, Judenhofer MS, Wiehr S, Pichler BJ (2009) Pre-clinical PET/MR: technological advances and new perspectives in biomedical research. Eur J Nucl Med Mol Imaging 36 (suppl 1): S56-S68
18. Moy L, Ponzo F, Noz ME et al (2007) Improving specificity of breast MRI using prone PET and fused MRI and PET 3D volume datasets. J Nucl Med 48(4):528-537
19. Antoch G, Bockisch A (2009) Combined PET/MRI: a new dimension in whole-body oncology imaging? Eur J Nucl Med Mol Imaging 36 (suppl 1): S113-S120
20. Eisenberg D P, Adusumilli PS, Hendershott KJ et al (2006) Real-time intraoperative detection of breast cancer axillary lymph node metastases using a green fluorescent protein-expressing herpes virus. Ann Surg 243(6):824-830; discussion 30-32
21. Brader P, Kelly K, Gang S et al (2009) Imaging of lymph node micrometastases using an oncolytic herpes virus and [F]FEAU PET. PLoS One 4(3):e4789
22. Floery D, Helbich TH, Riedl CC et al (2005) Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM): initial experience. Invest Radiol 40(6):328-335
23. Wang LV (1998) Optical tomography for biomedical applications. IEEE Eng Med Biol Mag 17(2):45-46
24. Mahmood U, Tung CH, Bogdanov A Jr, Weissleder R (1999) Near-infrared optical imaging of protease activity for tumor detection. Radiology 213(3):866-870
25. Jose J, Manohar S, Kolkman RG et al (2009) Imaging of tumor vasculature using Twente photoacoustic systems. J Biophotonics 2(12):701-717